Patent details

Basic Information

Publication number:

EP3302419

PCT Application Number:

EP2016061989

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP167273911

PCT Publication Number:

WO2016189125

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

NANOPARTICLES FOR USE AS A THERAPEUTIC VACCINE

French Title of Invention:

NANOPARTICULES POUR UNE UTILISATION COMME VACCIN THÉRAPEUTIQUE

German Title of Invention:

NANOPARTIKEL ZUR VERWENDUNG ALS THERAPEUTISCHER IMPFSTOFF

SPC Number:

Dates

Filing date:

27/05/2016

Grant date:

21/01/2026

EP Publication Date:

11/04/2018

PCT Publication Date:

01/12/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

21/01/2026

EP B1 Publication Date:

21/01/2026

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

27/05/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

14/01/2026

 

 

Name:

Nanobiotix

Address:

60 rue de Wattignies, 75012 Paris, France (FR)

Inventor

1

Name:

POTTIER, Agnès

Address:

France (FR)

2

Name:

LEVY, Laurent

Address:

France (FR)

3

Name:

MARILL, Julie

Address:

France (FR)

Priority

Priority Number:

15305810

Priority Date:

28/05/2015

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

A61K 9/00; A61N 5/10; A61K 9/51; A61K 33/24;

Publication

European Patent Bulletin

Issue number:

202604

Publication date:

21/01/2026

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

01/06/2026

Annual Fee Number:

11

Annual Fee Amount:

148 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages